<html>
<head>PUBMED IDs for C2orf34</head>
<body bgcolor='#C5F0F2'><h1>C2orf34</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15913950/'>The 2p21 deletion syndrome: characterization of the transcription content.</a> May 26  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16385448/'>Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.</a> December 31  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18234729/'>Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.</a> February 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18781961/'>Multi-system disorder syndromes associated with cystinuria type I.</a> September 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/23285036/'>Human calmodulin methyltransferase: expression, activity on calmodulin, and Hsp90 dependence.</a> June 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23285030/'>Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.</a> June 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23794250/'>Further delineation of genotype-phenotype correlation in homozygous 2p21 deletion syndromes: first description of patients without cystinuria.</a> October 18  2013<br></body></html>
